Stock listing
Valion Bio, Inc.
Selected listing: VBIO · NASDAQ · USD · US
Valion Bio, Inc. (NASDAQ:VBIO), Health Technology. Latest release Sep 23, 2026: Valion Appoints Life Sciences Veteran Dean Zikria as Interim CEO and Announces…
- Ticker
- NASDAQ:VBIO
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- NASDAQ
- Currency
- USD
About Valion Bio, Inc.
The company focuses on biotechnology and related sectors. Investors can find information about Valion Bio's performance and updates on its corporate activities on its dedicated public company page.
Latest news from Valion Bio, Inc.
Valion Appoints Life Sciences Veteran Dean Zikria as Interim CEO and Announces Board Leadership Transitions
September 23, 2026
Valion Bio Regains Compliance with NASDAQ Minimum Bid Price Listing Rule
September 22, 2026
Valion Bio Announces Reverse Stock Split
August 27, 2026
Valion Bio Announces U.S. Government-Funded Entolimod Studies Targeting Lethal Radiation-Induced GI Injury
August 12, 2026
Ukraine Ministry of Health Accepts Entolimod Dossier for Formal Review Under Regulatory Equivalence Pathway
July 22, 2026